Article Text

PDF
Screening of competitive athletes to prevent sudden death
  1. Gaetano Thiene1,
  2. Domenico Corrado1,
  3. Maurizio Schiavon2,
  4. Cristina Basso1
  1. 1Department of Cardiac, Thoracic and Vascular Sciences, University of Padua Medical School, Padua, Italy
  2. 2Center for Sports Medicine, Padua, Italy
  1. Correspondence to Professor Gaetano Thiene, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua Medical School, Via A. Gabelli, 61, Padua 35121, Italy; gaetano.thiene{at}unipd.it

Statistics from Altmetric.com

Sudden death (SD) in athletes represents a cardiac ‘earthquake’ affecting apparently healthy and highly trained individuals. This is not due to excessive demands on a normal heart, as occurred to Phidippides in Marathon, because our body has built-in safeguard mechanisms—dyspnea, angina, fatigue—to protect us from physical exhaustion. Autopsy investigations reveal that SD in athletes occurs three times more often than in non-athletes, and is caused by concealed cardiovascular abnormalities, mostly structural, that are unmasked by activity-triggered electrical instability.1–5 The structural culprits may be any of the cardiovascular components, including aorta, coronary arteries, myocardium, valves, conduction system and ion channels.1 The ECG is often abnormal, and its implementation in Italy for obligatory preparticipation screening has resulted in progressive reductions by 90% of SD in athletes aged 12–35 years between 1979 and 20024 (figure 1). This was mostly attributable to identification and disqualification of people affected by cardiomyopathies.

Figure 1

Annual incidence rates of sudden death (SD) per 100 000 person, among screened competitive athletes and unscreened non-athletes 12–35 years of age in the Veneto Region of Italy, from 1979 to 2002. During the study period (the nationwide preparticipation screening program was initiated in 1982), the annual incidence of SD declined by 89% in screened athletes (p for trend <0.001). In contrast, the incidence of SD did not demonstrate consistent changes over that time in unscreened non-athletes.

Arrhythmogenic right ventricular cardiomyopathy—unknown until the 1980s—is the major cause of SD in Italian athletes (relative risk 5.4 compared with non-athletes), and can now be identified at preparticipation screening by application of specific diagnostic criteria. Hypertrophic cardiomyopathy, on the other hand, was a rare cause of athlete SD in Italy compared with the US.4 ,6 In fact, abnormalities of the screening 12-lead ECG prompted echocardiography, which was diagnostic in …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles